This product review of the use of fremanezumab for the preventive treatment of migraine in adults.
This review discusses the evidence in support of the use of fremanezumab, its pharmacology including its mechanism of action, and efficacy and tolerability demonstrated in pivotal clinical trials. It also provides commentary and recommendations from Dr. Christina Sun-Edelstein a Neurologist with subspecialty training in Headache Medicine who runs the Headache Clinic at St. Vincent’s Hospital Melbourne and is a Senior Lecturer at the University of Melbourne.
Please login below to download this issue (PDF)